Germline PKHD1 mutations are protective against colorectal cancer
Christopher J. Ward(University of Kansas Medical Center), Peter C. Harris(Mayo Clinic), John R. Woollard(Mayo Clinic), Noralene M. Lindor(Mayo Clinic), Jason L. Bakeberg(Mayo Clinic), Gloria M. Petersen(Mayo Clinic), Vicente E. Torres(Mayo Clinic in Arizona), Ruth Johnson(Mayo Clinic), Marie C. Hogan(Mayo Clinic), Stephen N. Thibodeau(Mayo Clinic in Arizona), Yanhong Wu(Shandong University of Technology), Mine Cicek(University of New Mexico), Christina M. Heyer(Mayo Clinic), Sandro Rossetti(Mayo Clinic), Eric J. Bergstralh(Mayo Clinic)
Cited by 31
Related Papers
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Mutation of a <i>mutL</i> Homolog in Hereditary Colon Cancer
|Science|1994|1.8k
The Molecular Basis of Turcot's Syndrome
|New England Journal of Medicine|1995|1.1k